Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |